LD 919 LR 1724(02)
An Act To Provide Access to Opioid Analgesics with Abuse-deterrent Properties
Fiscal Note for Bill as Amended by Committee Amendment " "
Committee: Insurance and Financial Services
Fiscal Note Required: Yes
Fiscal Note
Potential future biennium cost increase - All Funds
Fiscal Detail and Notes
The proposed law would not have any fiscal impact in the current biennium to the state employee health plan because non-abuse-deterrent opioids and abuse-deterrent opioids are currently on the same tiers in the formulary for the plan, so there is no cost differential.

To the extent that the State Employee Health Commission (SEHC) might want to adjust formularies in the future to guide members toward lower cost generic non-abuse-deterrent opioids, the SEHC would be precluded from doing so by this legislation. That could lead to future increased costs due to an inability to utilize that option to achieve savings.